Gain Therapeutics, Inc. has announced that Dr. Joanne Taylor will present the company's lead drug candidate, GT-02287, at the upcoming AD/PD™ 2025 Conference in Vienna, Austria. GT-02287 is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback